-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LTI-01 in Empyema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LTI-01 in Empyema report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.LTI-01 in EmpyemaDrug Details:LTI-01 is under development for the treatment of loculated pleural effusions...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SerpinPC in Hemophilia B (Factor IX Deficiency)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SerpinPC in Hemophilia B (Factor IX Deficiency) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SerpinPC in Hemophilia B (Factor IX Deficiency) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABTL-0812 in Pancreatic Ductal Adenocarcinoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.ABTL-0812 in Pancreatic Ductal AdenocarcinomaDrug Details:ABTL-0812 is under development for the treatment of advanced solid tumors...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PR-006 in Frontotemporal Dementia (FTD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PR-006 in Frontotemporal Dementia (FTD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.PR-006 in Frontotemporal Dementia (FTD)Drug Details:PR-006 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LY-2510924 in Refractory Acute Myeloid Leukemia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.LY-2510924 in Refractory Acute Myeloid LeukemiaDrug Details:LY2510924 is under development for the treatment of relapsed or...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RP-12146 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RP-12146 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.RP-12146 in Solid Tumor Drug Details:RP-12146 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lipocurc in High-Grade Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lipocurc in High-Grade Glioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Lipocurc in High-Grade GliomaDrug Details:Liposomal curcumin is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MP-0250 in Relapsed Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MP-0250 in Relapsed Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.MP-0250 in Relapsed Multiple MyelomaDrug Details:MP-0250 is under development for the treatment...